A Pancancer Study of PIEZO1 as a Prognosis and Immune Biomarker of Human Tumors

Figure 4

Mutation features of PIEZO1 in TCGA tumors. CBioPortal tool was utilized to explore the mutation status of PIEZO1 across TCGA tumors. (a) The type of alteration frequency. (b) The mutation site. (c) Based on the cBioPortal tool, the correlation between gene mutation and OS, disease-specific survival (DSS), DFS, and progression-free survival (PFS) of UCEC was analyzed and presented.

(a)

(b)

(c)